These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35572555)

  • 1. Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2.
    Sengupta S; Bhattacharya G; Chatterjee S; Datey A; Shaw SK; Suranjika S; Nath P; Barik PK; Prasad P; Chattopadhyay S; Swain RK; Parida A; Devadas S
    Front Immunol; 2022; 13():848335. PubMed ID: 35572555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns.
    Vazquez-Alejo E; Tarancon-Diez L; Carrasco I; Vigil-Vázquez S; Muñoz-Chapuli M; Rincón-López E; Saavedra-Lozano J; Santos-Sebastián M; Aguilera-Alonso D; Hernanz-Lobo A; Santiago-García B; de León-Luis JA; Muñoz P; Sánchez-Luna M; Navarro ML; Muñoz-Fernández MÁ
    Front Immunol; 2022; 13():947549. PubMed ID: 35911743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients.
    Srivastava A; Rockman-Greenberg C; Sareen N; Lionetti V; Dhingra S
    Mol Cell Biochem; 2022 Jun; 477(6):1681-1695. PubMed ID: 35235124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.
    Chatterjee S; Datey A; Sengupta S; Ghosh A; Jha A; Walia S; Singh S; Suranjika S; Bhattacharya G; Laha E; Keshry SS; Ray A; Pani SS; Suryawanshi AR; Dash R; Senapati S; Beuria TK; Syed GH; Prasad P; Raghav SK; Devadas S; Swain RK; Chattopadhyay S; Parida A
    Front Cell Infect Microbiol; 2021; 11():725035. PubMed ID: 34993157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection.
    Singh M; Barrera Adame O; Nickas M; Robison J; Khatchadourian C; Venketaraman V
    Front Immunol; 2022; 13():833355. PubMed ID: 35401518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential immune response in mild versus fatal SARS-CoV2 infection.
    Suster D; Tili E; Nuovo GJ
    Ann Diagn Pathol; 2022 Dec; 61():152032. PubMed ID: 36113259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report.
    Pal R; Sachdeva N; Mukherjee S; Suri V; Zohmangaihi D; Ram S; Puri GD; Bhalla A; Soni SL; Pandey N; Bhansali A; Bhadada SK
    Diabetes Metab Syndr; 2021; 15(1):193-196. PubMed ID: 33385765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
    Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.
    Samson M; Nicolas B; Ciudad M; Greigert H; Guilhem A; Cladiere C; Straub C; Blot M; Piroth L; Rogier T; Devilliers H; Manckoundia P; Ghesquiere T; Francois S; Lakomy D; Audia S; Bonnotte B
    Eur J Intern Med; 2022 Aug; 102():104-109. PubMed ID: 35690570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    Richardson JR; Götz R; Mayr V; Lohse MJ; Holthoff HP; Ungerer M
    PLoS One; 2022; 17(4):e0266701. PubMed ID: 35468147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.